|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Neurology and Center for Neuroscience and Regeneration Research Yale University School of Medicine, New Haven, and Rehabilitation Research Center, VA Connecticut Healthcare System, West Haven, CT.
Address correspondence and reprint requests to Dr Waxman, Department of Neurology, Yale University School of Medicine, 333 Cedar St., LCI-707, New Haven, CT 06510; e-mail: Stephen.Waxman{at}yale.edu
Background: Inherited erythermalgia (also termed "erythromelalgia"), characterized by episodic burning pain in the distal extremities evoked by warmth, has been causally linked with mutations of the Nav1.7 sodium channel, which is preferentially expressed in nociceptors. Thus far, Nav1.7 mutations within intracellular linker parts of the channel have been physiologically characterized.
Objective: To investigate a Nav1.7 erythermalgia mutation that substitutes one uncharged amino acid for another within an S4 segment.
Methods: Whole-cell patch-clamp analysis was used to study biophysical properties of wild-type and mutant (F216S) Nav1.7 channels in mammalian cells.
Results: The F216S mutation hyperpolarizes the voltage dependence of activation by 11 mV, accelerates activation, slows deactivation, and enhances the response to slow, small depolarizations.
Conclusion: These results provide a physiologic basis for the linkage to erythermalgia of an Nav1.7 mutation that substitutes one uncharged residue for another within an S4 segment of the channel. These changes should increase excitability of nociceptive dorsal root ganglion neurons in which the mutant channel is present, thus contributing to pain.
Editorial, see page 1538
This article was previously published in electronic format as an Expedited E-Pub on September 20, 2006, at www.neurology.org.
Supported in part by grants from the National Multiple Sclerosis Society, the Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs, and the Erythromelalgia Association. The Center for Neuroscience and Regeneration Research is a Collaboration of the Paralyzed Veterans of America and the United Spinal Association with Yale University.
Disclosure: The authors report no conflicts of interest.
Received March 15, 2006. Accepted in final form May 30, 2006.
This article has been cited by other articles:
![]() |
C. Han, S. D. Dib-Hajj, Z. Lin, Y. Li, E. M. Eastman, L. Tyrrell, X. Cao, Y. Yang, and S. G. Waxman Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation Brain, July 1, 2009; 132(7): 1711 - 1722. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schorge and D. M. Kullmann Sodium channelopathy of peripheral nerve: tightening the genotype-phenotype relationship Brain, July 1, 2009; 132(7): 1690 - 1692. [Full Text] [PDF] |
||||
![]() |
M. Estacion, S. D. Dib-Hajj, P. J. Benke, R. H. M. te Morsche, E. M. Eastman, L. J. Macala, J. P. H. Drenth, and S. G. Waxman NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both Disorders J. Neurosci., October 22, 2008; 28(43): 11079 - 11088. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Jarecki, P. L. Sheets, J. O. Jackson II, and T. R. Cummins Paroxysmal extreme pain disorder mutations within the D3/S4-S5 linker of Nav1.7 cause moderate destabilization of fast inactivation J. Physiol., September 1, 2008; 586(17): 4137 - 4153. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lampert, A. O. O'Reilly, S. D. Dib-Hajj, L. Tyrrell, B. A. Wallace, and S. G. Waxman A Pore-blocking Hydrophobic Motif at the Cytoplasmic Aperture of the Closed-state Nav1.7 Channel Is Disrupted by the Erythromelalgia-associated F1449V Mutation J. Biol. Chem., August 29, 2008; 283(35): 24118 - 24127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chattopadhyay, M. Mata, and D. J. Fink Continuous {delta}-Opioid Receptor Activation Reduces Neuronal Voltage-Gated Sodium Channel (NaV1.7) Levels through Activation of Protein Kinase C in Painful Diabetic Neuropathy J. Neurosci., June 25, 2008; 28(26): 6652 - 6658. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. H. Drenth, R. H. M. te Morsche, S. Mansour, and P. S. Mortimer Primary Erythermalgia as a Sodium Channelopathy: Screening for SCN9A Mutations: Exclusion of a Causal Role of SCN10A and SCN11A Arch Dermatol, March 1, 2008; 144(3): 320 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schorge and L. J. Pacek Inherited erythermalgia moves a sodium channel into focus. Neurology, November 14, 2006; 67(9): 1538 - 1539. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |